Filtered By:
Management: Marketing
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 200 results found since Jan 2013.
City Heat is Worse if You ’re Not Rich or White. The World’s First Heat Officer Wants to Change That
Jane Gilbert knows she doesn’t get the worst of the sticky heat and humidity that stifles Miami each summer. She lives in Morningside, a coastal suburb of historically preserved art deco and Mediterranean-style single-family homes. Abundant trees shade the streets and a bay breeze cools residents when they leave their air conditioned cars and homes. “I live in a place of privilege and it’s a beautiful area,” says Gilbert, 58, over Zoom in early June, shortly after beginning her job as the world’s first chief heat officer, in Miami Dade county. “But you don’t have to go far to see t...
Source: TIME: Science - July 7, 2021 Category: Science Authors: Ciara Nugent Tags: Uncategorized climate change feature Londontime Source Type: news
Artificial Neural Network Analyzing Wearable Device Gait Data for Identifying Patients With Stroke Unable to Return to Work
A potential dramatic effect of long-term disability due to stroke is the inability to return to work. An accurate prognosis and the identification of the parameters inflating the possibility of return to work after neurorehabilitation are crucial. Many factors may influence it, such as mobility and, in particular, walking ability. In this pilot study, two emerging technologies have been combined with the aim of developing a prognostic tool for identifying patients able to return to work: a wearable inertial measurement unit for gait analysis and an artificial neural network (ANN). Compared with more conventional statistics...
Source: Frontiers in Neurology - May 19, 2021 Category: Neurology Source Type: research
FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(R) IND for Stroke Treatment
FDA Responds to Company's IND #27375 Including Pharmacology, Manufacturing and Clinical Sections
PHOENIX, May 14, 2021 -- (Healthcare Sales & Marketing Network) -- Creative Medical Technology Holdings Inc., trading under ticker symbol CELZ, announced t... Regenerative Medicine, Neurology, FDA Creative Medical Technology, ImmCelz, stroke
Source: HSMN NewsFeed - May 14, 2021 Category: Pharmaceuticals Source Type: news
Neurolutions IpsiHand Upper Extremity Rehabilitation System
U.S. FDA authorizes marketing of Neurolutions IpsiHand Upper Extremity Rehabilitation System to facilitate muscle rehabilitation in stroke patients
Source: Disabled World - April 24, 2021 Category: Disability Tags: FDA Approvals Source Type: news
Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by ove...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
MIVI Neuroscience Secures Series B Funding
EDEN PRAIRIE, Minn., Jan. 21, 2021 -- (Healthcare Sales & Marketing Network) -- MIVI Neuroscience, a medical device company focused on improving clinical outcomes for ischemic stroke patients, today announced the closing of its Series B funding including ... Devices, Interventional, Neurology, Venture Capital MIVI Neuroscience, Q Aspiration System, DAISe , Thrombectomy
Source: HSMN NewsFeed - January 21, 2021 Category: Pharmaceuticals Source Type: news
Elevian Announces $15 Million Equity Financing
Company Expands Leadership Team as it Advances Preclinical Studies of rGDF11 in Stroke and Other Age-Related Diseases
ALLSTON, Mass., Nov. 24, 2020 -- (Healthcare Sales & Marketing Network) -- Elevian, an emerging biotech company developing medicines t... Biopharmaceuticals, Regenerative Medicine, Venture Capital Elevian, age-related disease, GDF11
Source: HSMN NewsFeed - November 24, 2020 Category: Pharmaceuticals Source Type: news
Rapid Medical Expands Comaneci(TM) CE Mark Indication to Include Vasospasm Treatment
Comaneci is the first adjustable mesh device indicated for the endovascular treatment of vasospasm
YOKNEAM, Israel, Nov. 23, 2020 -- (Healthcare Sales & Marketing Network) -- Rapid Medical, a company focused on the development of next-generation neurov... Devices, Interventional, Neurology, Regulatory Rapid Medical, TIGERTRIEVER, thrombectomy, stroke, vasospasm
Source: HSMN NewsFeed - November 23, 2020 Category: Pharmaceuticals Source Type: news
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation
MARLBOROUGH, Mass., Oct. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporatio... Devices, Interventional, Cardiology Boston Scientific, WATCHMAN FLX, Left Atrial Appendage, atrial fibrillation
Source: HSMN NewsFeed - October 29, 2020 Category: Pharmaceuticals Source Type: news
Finding the everyday miracles in life
Last week I was writing about what it takes for a miracle to happen and one of my commentators, the lovely Patsy Collins who joined me on the podcast not that long ago, pointed out that there are all sorts of miracles that happen, including some everyday miracles we never know about, because they happen behind the scenes.
And it got me thinking about the all the little miracles that have happened in my life over the years. And, once I got thinking, I got into musing about what life would be like if they hadn’t happened. And, as it’s been a week of ups and downs on the exam front I thought I might as well start ...
Source: The Hysterectomy Association - August 22, 2020 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Happiness miracle Source Type: news
Rapid Medical Receives CE Mark for TIGERTRIEVER(TM) XL
TIGERTRIEVER XL is the largest stentriever available, designed to safely remove clots from intracranial vessels up to 9mm in diameter
YOKNEAM, Israel, July 27, 2020 -- (Healthcare Sales & Marketing Network) -- Rapid Medical, a company focused on the de... Devices, Interventional, Neurology, Regulatory Rapid Medical, TIGERTRIEVER, thrombectomy device, stroke
Source: HSMN NewsFeed - July 27, 2020 Category: Pharmaceuticals Source Type: news
Rapid Medical Announces Ahead of Schedule Completion of Patient Enrollment for the TIGER Clinical Study for TIGERTRIEVER Thrombectomy Device
YOKNEAM, Israel, April 7, 2020 -- (Healthcare Sales & Marketing Network) -- Rapid Medical, a company focused on the development of next generation neurovascular interventional devices, has announced that it has completed enrollment in the TIGER (Treatment... Devices, Interventional, Radiology, Neurology Rapid Medical, TIGERTRIEVER, thrombectomy, stroke
Source: HSMN NewsFeed - April 7, 2020 Category: Pharmaceuticals Source Type: news
Medication Adherence and Stroke Prevention: What Real World Data Tells Us.
Authors: Hsieh CY
Abstract
Medication adherence, by definition,(2) is "the extent to which a patient acts in accordance with the prescribed interval and dose of a dosing regimen." Poor medication adherence can interfere with the ability to treat many diseases, leading to greater complications and a lower quality of life.(3) In this issue of Acta Neurologica Taiwanica, Chen et al.(4) presented the inverse association between adherence of antithrombotic agents and poor outcomes after a first-ever ischemic stroke. The findings were consistent with Sung, et al.(5) that medication nonadherence are prevalent in young adu...
Source: Acta Neurologica Taiwanica - February 7, 2020 Category: Neurology Tags: Acta Neurol Taiwan Source Type: research
What ’s the Big Deal about Data in Medtech?
Discussion, “Top 5 Things You Need to Know about the Implantable Internet of Things."
Brian Chapman, partner and leader of ZS’s medtech practice of ZS, attributes today’s focus on data to the intersection of two important things:
"A general recognition that understanding more and connecting actions with outcomes will provide feedback and understanding that will drive standards of care. This is not new, but as capabilities rise in data collection, aggregation, and synthesize rise, and coupled with machine learning, the promise of data in healthcare is becoming even more ...
Source: MDDI - December 20, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news
